[After the pharmacology-driven euphoria--a new chance for developing and implementing of psychosocial interventions].
Richter
Dirk
D
Hoffmann
Holger
H
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003865:Major Depressive Disorder / Q000628:therapy*; D005059:Euphoria; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D010342:Patient Acceptance of Health Care; D017060:Patient Satisfaction; D011613:Psychotherapy / Q000379:methods*; D017594:Publication Bias; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors